Skip to main content
SpringerLink
Log in

Mass Spectrometric DNA Adduct Quantification by Multiple Reaction Monitoring and Its Future Use for the Molecular Epidemiology of Cancer

  • Chapter
  • First Online:
Advancements of Mass Spectrometry in Biomedical Research

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1140))

Abstract

The formation of DNA adducts is considered essential for tumor initiation. Quantification of DNA adducts may be achieved by various techniques of which LC-MS/MS-based multiple reaction monitoring has become the most prominent in the past decade. Adducts of single nucleosides are analyzed following enzymatic break-down of a DNA sample following adduct enrichment usually by solid-phase extraction. LC-MS/MS quantification is carried out using stable isotope-labeled internal reference substances. An upcoming challenge is the use of DNA adducts as biomarkers either for internal exposure to electrophilic genotoxins or for the approximation of cancer risk. Here we review recent studies in which DNA adducts were quantified by LC-MS/MS in DNA samples from human matrices. We outline a possible way for future research to aim at the development of an ‘adductome’ approach for the characterization of DNA adduct spectra in human tissues. The DNA adduct spectrum reflects the inner exposure of an individual’s tissue to electrophilic metabolites and, therefore, should replace the conventional and inaccurate external exposure in epidemiological studies in the future.

This chapter is unchanged from the first edition.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

2-AAF:

2-Acetylaminofluorene

4-ABP:

4-Aminobiphenyl

BaP:

Benzo[a]pyrene

CYP:

Cytochrome P450 monooxygenase

dA:

2′-Deoxyadenosine

dC:

2′-Deoxycytidine

dG:

2′-Deoxyguanosine

HAA:

Heterocyclic aromatic amine

LC-MS/MS:

Liquid chromatography–tandem mass spectrometry

MP:

1-Methylpyrene

MRM:

Multiple reaction monitoring

PAH:

Polycyclic aromatic hydrocarbon

PhIP:

2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine

TLC:

Thin-layer chromatography

References

  1. Hanahan, D., & Weinberg, R. A. (2000). The hallmarks of cancer. Cell, 100, 57–70.

    CAS  Google Scholar 

  2. International Agency for Research on Cancer. (2010). Some aromatic amines, organic dyes, and related exposures (Vol. 99). Lyon: International Agency for Research on Cancer.

    Google Scholar 

  3. International Agency for Research on Cancer. (2010). Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures (Vol. 92). Lyon: International Agency for Research on Cancer.

    Google Scholar 

  4. International Agency for Research on Cancer. (2007). Smokeless tobacco and some tobacco-specific N-nitrosamines (Vol. 89). Lyon: International Agency for Research on Cancer.

    Google Scholar 

  5. Guengerich, F. P. (2003). Activation of dihaloalkanes by thiol-dependent mechanisms. Journal of Biochemistry and Molecular Biology, 36, 20–27.

    CAS  PubMed  Google Scholar 

  6. International Agency for Research on Cancer. (2008). 1,3-butadiene, ethylene oxide and vinyl halides (vinyl fluoride, vinyl chloride and vinyl bromide) (Vol. 97). Lyon: International Agency for Research on Cancer.

    Google Scholar 

  7. Guengerich, F. P., Johnson, W. W., Shimada, T., Ueng, Y. F., Yamazaki, H., & Langouet, S. (1998). Activation and detoxication of aflatoxin B1. Mutation Research, 402, 121–128.

    CAS  PubMed  Google Scholar 

  8. Kim, J. H., Stansbury, K. H., Walker, N. J., Trush, M. A., Strickland, P. T., & Sutter, T. R. (1998). Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1. Carcinogenesis, 19, 1847–1853.

    CAS  PubMed  Google Scholar 

  9. Shou, M., Korzekwa, K. R., Crespi, C. L., Gonzalez, F. J., & Gelboin, H. V. (1994). The role of 12 cDNA-expressed human, rodent, and rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and benzo[a]pyrene trans-7,8-dihydrodiol. Molecular Carcinogenesis, 10, 159–168.

    CAS  PubMed  Google Scholar 

  10. Rendic, S., & Guengerich, F. P. (2012). Contributions of human enzymes in carcinogen metabolism. Chemical Research in Toxicology, 25, 1316–1383.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Otteneder, M., & Lutz, W. K. (1999). Correlation of DNA adduct levels with tumor incidence: Carcinogenic potency of DNA adducts. Mutation Research, 424, 237–247.

    CAS  PubMed  Google Scholar 

  12. Poirier, M. C., & Beland, F. A. (1992). DNA adduct measurements and tumor incidence during chronic carcinogen exposure in animal models: Implications for DNA adduct-based human cancer risk assessment. Chemical Research in Toxicology, 5, 749–755.

    CAS  PubMed  Google Scholar 

  13. Randerath, K., Reddy, M. V., & Gupta, R. C. (1981). 32P-labeling test for DNA damage. Proceedings of the National Academy of Sciences of the United States of America, 78, 6126–6129.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Farmer, P. B., & Singh, R. (2008). Use of DNA adducts to identify human health risk from exposure to hazardous environmental pollutants: The increasing role of mass spectrometry in assessing biologically effective doses of genotoxic carcinogens. Mutation Research, 659, 68–76.

    CAS  PubMed  Google Scholar 

  15. Klaene, J. J., Sharma, V. K., Glick, J., & Vouros, P. (2012). The analysis of DNA adducts: The transition from 32P-postlabeling to mass spectrometry. Cancer Letters, 334, 10–19.

    PubMed  PubMed Central  Google Scholar 

  16. Angerer, J., Ewers, U., & Wilhelm, M. (2007). Human biomonitoring: State of the art. International Journal of Hygiene and Environmental Health, 210, 201–228.

    CAS  PubMed  Google Scholar 

  17. Godschalk, R. W., Van Schooten, F. J., & Bartsch, H. (2003). A critical evaluation of DNA adducts as biological markers for human exposure to polycyclic aromatic compounds. Journal of Biochemistry and Molecular Biology, 36, 1–11.

    CAS  PubMed  Google Scholar 

  18. Phillips, D. H. (2002). Smoking-related DNA and protein adducts in human tissues. Carcinogenesis, 23, 1979–2004.

    CAS  PubMed  Google Scholar 

  19. Vineis, P., & Husgafvel-Pursiainen, K. (2005). Air pollution and cancer: Biomarker studies in human populations. Carcinogenesis, 26, 1846–1855.

    CAS  PubMed  Google Scholar 

  20. Poirier, M. C., Stanley, J. R., Beckwith, J. B., Weinstein, I. B., & Yuspa, S. H. (1982). Indirect immunofluorescent localization of benzo[a]pyrene adducted to nucleic acids in cultured mouse keratinocyte nuclei. Carcinogenesis, 3, 345–348.

    CAS  PubMed  Google Scholar 

  21. Spodheim-Maurizot, M., Saint-Ruf, G., & Leng, M. (1980). Antibodies to N-hydroxy-2-aminofluorene modified DNA as probes in the study of DNA reacted with derivatives of 2-acetylaminofluorene. Carcinogenesis, 1, 807–812.

    CAS  PubMed  Google Scholar 

  22. Baasanjav-Gerber, C., Monien, B. H., Mewis, I., Schreiner, M., Barillari, J., Iori, R., et al. (2011). Identification of glucosinolate congeners able to form DNA adducts and to induce mutations upon activation by myrosinase. Molecular Nutrition & Food Research, 55, 783–792.

    CAS  Google Scholar 

  23. Farmer, P. B., Brown, K., Tompkins, E., Emms, V. L., Jones, D. J., Singh, R., et al. (2005). DNA adducts: Mass spectrometry methods and future prospects. Toxicology and Applied Pharmacology, 207, 293–301.

    CAS  PubMed  Google Scholar 

  24. Monien, B. H., Müller, C., Engst, W., Frank, H., Seidel, A., & Glatt, H. R. (2008). Time course of hepatic 1-methylpyrene DNA adducts in rats determined by isotope dilution LC-MS/MS and 32P-postlabeling. Chemical Research in Toxicology, 21, 2017–2025.

    CAS  PubMed  Google Scholar 

  25. Felton, J. S., Knize, M. G., Shen, N. H., Lewis, P. R., Andresen, B. D., Happe, J., et al. (1986). The isolation and identification of a new mutagen from fried ground beef: 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis, 7, 1081–1086.

    CAS  PubMed  Google Scholar 

  26. Glatt, H. R. (2006). Metabolic factors affecting the mutagenicity of heterocyclic amines. In K. Skog & J. Alexander (Eds.), Acrylamide and other health hazardous compounds in heat-treated foods (pp. 358–404). Cambridge: Woodhead Publishing.

    Google Scholar 

  27. Monien, B. H., Engst, W., Barknowitz, G., Seidel, A., & Glatt, H. R. (2012). Mutagenicity of 5-hydroxymethylfurfural in V79 cells expressing human SULT1A1: Identification and mass spectrometric quantification of DNA adducts formed. Chemical Research in Toxicology, 25, 1484–1492.

    CAS  PubMed  Google Scholar 

  28. Monien, B. H., Herrmann, K., Florian, S., & Glatt, H. R. (2011). Metabolic activation of furfuryl alcohol: Formation of 2-methylfuranyl DNA adducts in Salmonella typhimurium strains expressing human sulfotransferase 1A1 and in FVB/N mice. Carcinogenesis, 32, 1533–1539.

    CAS  PubMed  Google Scholar 

  29. Monien, B. H., Müller, C., Bakhiya, N., Donath, C., Frank, H., Seidel, A., et al. (2009). Probenecid, an inhibitor of transmembrane organic anion transporters, alters tissue distribution of DNA adducts in 1-hydroxymethylpyrene-treated rats. Toxicology, 262, 80–85.

    CAS  PubMed  Google Scholar 

  30. Punt, A., Delatour, T., Scholz, G., Schilter, B., van Bladeren, P. J., & Rietjens, I. M. (2007). Tandem mass spectrometry analysis of N2-(trans-isoestragol-3′-yl)-2′-deoxyguanosine as a strategy to study species differences in sulfotransferase conversion of the proximate carcinogen 1′-hydroxyestragole. Chemical Research in Toxicology, 20, 991–998.

    CAS  PubMed  Google Scholar 

  31. Beland, F. A., Doerge, D. R., Churchwell, M. I., Poirier, M. C., Schoket, B., & Marques, M. M. (1999). Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard. Chemical Research in Toxicology, 12, 68–77.

    CAS  PubMed  Google Scholar 

  32. Singh, R., Gaskell, M., Le Pla, R. C., Kaur, B., Azim-Araghi, A., Roach, J., et al. (2006). Detection and quantitation of benzo[a]pyrene-derived DNA adducts in mouse liver by liquid chromatography-tandem mass spectrometry: Comparison with 32P-postlabeling. Chemical Research in Toxicology, 19, 868–878.

    CAS  PubMed  Google Scholar 

  33. Goodenough, A. K., Schut, H. A., & Turesky, R. J. (2007). Novel LC-ESI/MS/MS(n) method for the characterization and quantification of 2′-deoxyguanosine adducts of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by 2-D linear quadrupole ion trap mass spectrometry. Chemical Research in Toxicology, 20, 263–276.

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Phillips, D. H., & Castegnaro, M. (1999). Standardization and validation of DNA adduct postlabelling methods: Report of interlaboratory trials and production of recommended protocols. Mutagenesis, 14, 301–315.

    CAS  PubMed  Google Scholar 

  35. Reddy, M. V. (2000). Methods for testing compounds for DNA adduct formation. Regulatory Toxicology and Pharmacology, 32, 256–263.

    CAS  PubMed  Google Scholar 

  36. Paini, A., Scholz, G., Marin-Kuan, M., Schilter, B., O’Brien, J., van Bladeren, P. J., et al. (2011). Quantitative comparison between in vivo DNA adduct formation from exposure to selected DNA-reactive carcinogens, natural background levels of DNA adduct formation and tumour incidence in rodent bioassays. Mutagenesis, 26, 605–618.

    CAS  PubMed  Google Scholar 

  37. Ma, L., Kuhlow, A., & Glatt, H. R. (2002). Ethanol enhances the activation of 1-hydroxymethylpyrene to DNA adduct-forming species in the rat. Polycyclic Aromatic Compounds, 22, 933–946.

    CAS  Google Scholar 

  38. Smith, B., Cadby, P., Leblanc, J. C., & Setzer, R. W. (2010). Application of the margin of exposure (MoE) approach to substances in food that are genotoxic and carcinogenic: Example: Methyleugenol, CASRN: 93-15-2. Food and Chemical Toxicology, 48(Suppl 1), S89–S97.

    CAS  PubMed  Google Scholar 

  39. Ricicki, E. M., Soglia, J. R., Teitel, C., Kane, R., Kadlubar, F., & Vouros, P. (2005). Detection and quantification of N-(deoxyguano-sin-8-yl)-4-aminobiphenyl adducts in human pancreas tissue using capillary liquid chromatography-microelectrospray mass spectrometry. Chemical Research in Toxicology, 18, 692–699.

    Google Scholar 

  40. Zhang, S., Balbo, S., Wang, M., & Hecht, S. S. (2010). Analysis of acrolein-derived 1,N2-propanodeoxyguanosine adducts in human leukocyte DNA from smokers and nonsmokers. Chemical Research in Toxicology, 24, 119–124.

    PubMed  PubMed Central  Google Scholar 

  41. Chen, L., Wang, M., Villalta, P. W., Luo, X., Feuer, R., Jensen, J., et al. (2007). Quantitation of an acetaldehyde adduct in human leukocyte DNA and the effect of smoking cessation. Chemical Research in Toxicology, 20, 108–113.

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Embrechts, J., Lemiere, F., Van Dongen, W., Esmans, E. L., Buytaert, P., Van Marck, E., et al. (2003). Detection of estrogen DNA-adducts in human breast tumor tissue and healthy tissue by combined nano LC-nano ES tandem mass spectrometry. Journal of the American Society for Mass Spectrometry, 14, 482–491.

    CAS  PubMed  Google Scholar 

  43. Bessette, E. E., Spivack, S. D., Goodenough, A. K., Wang, T., Pinto, S., Kadlubar, F. F., et al. (2010). Identification of carcinogen DNA adducts in human saliva by linear quadrupole ion trap/multistage tandem mass spectrometry. Chemical Research in Toxicology, 23, 1234–1244.

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Brown, K., Tompkins, E. M., Boocock, D. J., Martin, E. A., Farmer, P. B., Turteltaub, K. W., et al. (2007). Tamoxifen forms DNA adducts in human colon after administration of a single [14C]-labeled therapeutic dose. Cancer Research, 67, 6995–7002.

    CAS  PubMed  Google Scholar 

  45. Gu, D., Turesky, R. J., Tao, Y., Langouet, S. A., Nauwelaers, G. C., Yuan, J. M., et al. (2012). DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 4-aminobiphenyl are infrequently detected in human mammary tissue by liquid chromatography/tandem mass spectrometry. Carcinogenesis, 33, 124–130.

    CAS  PubMed  Google Scholar 

  46. Zhu, J., Chang, P., Bondy, M. L., Sahin, A. A., Singletary, S. E., Takahashi, S., et al. (2003). Detection of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine-DNA adducts in normal breast tissues and risk of breast cancer. Cancer Epidemiology, Biomarkers & Prevention, 12, 830–837.

    CAS  Google Scholar 

  47. Gorlewska-Roberts, K., Green, B., Fares, M., Ambrosone, C. B., & Kadlubar, F. F. (2002). Carcinogen-DNA adducts in human breast epithelial cells. Environmental and Molecular Mutagenesis, 39, 184–192.

    CAS  PubMed  Google Scholar 

  48. Perera, F., Mayer, J., Jaretzki, A., Hearne, S., Brenner, D., Young, T. L., et al. (1989). Comparison of DNA adducts and sister chromatid exchange in lung cancer cases and controls. Cancer Research, 49, 4446–4451.

    CAS  PubMed  Google Scholar 

  49. Tang, D., Phillips, D. H., Stampfer, M., Mooney, L. A., Hsu, Y., Cho, S., et al. (2001). Association between carcinogen-DNA adducts in white blood cells and lung cancer risk in the physicians health study. Cancer Research, 61, 6708–6712.

    CAS  PubMed  Google Scholar 

  50. Newcomb, P. A., Solomon, C., & White, E. (1999). Tamoxifen and risk of large bowel cancer in women with breast cancer. Breast Cancer Research and Treatment, 53, 271–277.

    CAS  PubMed  Google Scholar 

  51. Qian, G. S., Ross, R. K., Yu, M. C., Yuan, J. M., Gao, Y. T., Henderson, B. E., et al. (1994). A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People’s Republic of China. Cancer Epidemiology, Biomarkers & Prevention, 3, 3–10.

    CAS  Google Scholar 

  52. Nair, J., Carmichael, P. L., Fernando, R. C., Phillips, D. H., Strain, A. J., & Bartsch, H. (1998). Lipid peroxidation-induced etheno-DNA adducts in the liver of patients with the genetic metal storage disorders Wilson’s disease and primary hemochromatosis. Cancer Epidemiology, Biomarkers & Prevention, 7, 435–440.

    CAS  Google Scholar 

  53. Bartsch, H., Arab, K., & Nair, J. (2011). Biomarkers for hazard identification in humans. Environmental Health, 10(Suppl 1), S11.

    PubMed  PubMed Central  Google Scholar 

  54. Poirier, M. C. (2004). Chemical-induced DNA damage and human cancer risk. Nature Reviews. Cancer, 4, 630–637.

    CAS  PubMed  Google Scholar 

  55. Singh, R., Teichert, F., Seidel, A., Roach, J., Cordell, R., Cheng, M. K., et al. (2010). Development of a targeted adductomic method for the determination of polycyclic aromatic hydrocarbon DNA adducts using online column-switching liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry, 24, 2329–2340.

    CAS  PubMed  Google Scholar 

  56. Chou, P. H., Kageyama, S., Matsuda, S., Kanemoto, K., Sasada, Y., Oka, M., et al. (2010). Detection of lipid peroxidation-induced DNA adducts caused by 4-oxo-2(E)-nonenal and 4-oxo-2(E)-hexenal in human autopsy tissues. Chemical Research in Toxicology, 23, 1442–1448.

    CAS  PubMed  Google Scholar 

  57. Matsuda, T., Tao, H., Goto, M., Yamada, H., Suzuki, M., Wu, Y., et al. (2013). Lipid peroxidation-induced DNA adducts in human gastric mucosa. Carcinogenesis, 34, 121–127.

    CAS  PubMed  Google Scholar 

  58. Benford, D., Bolger, P. M., Carthew, P., Coulet, M., DiNovi, M., Leblanc, J. C., et al. (2010). Application of the Margin of Exposure (MOE) approach to substances in food that are genotoxic and carcinogenic. Food and Chemical Toxicology, (48 Suppl 1), S2–S24.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The author gratefully acknowledges financial support from the German Research Foundation (MO 2520/1-1) and the German Institute of Human Nutrition (DIfE).

Author information

Authors and Affiliations

  1. German Institute of Human Nutrition (DIfE) Potsdam Rehbrücke, Nuthetal, Germany

    Bernhard H. Monien

  2. Department of Food Safety, Federal Institute for Risk Assessment, Unit 54, Berlin, Germany

    Bernhard H. Monien

Authors
  1. Bernhard H. Monien
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bernhard H. Monien .

Editor information

Editors and Affiliations

  1. Biochemistry and Proteomics Group, Department of Chemistry and Biomolecular Science, Clarkson University, Potsdam, NY, USA

    Alisa G. Woods

  2. Biochemistry and Proteomics Group, Department of Chemistry and Biomolecular Science, Clarkson University, Potsdam, NY, USA

    Costel C. Darie

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Monien, B.H. (2019). Mass Spectrometric DNA Adduct Quantification by Multiple Reaction Monitoring and Its Future Use for the Molecular Epidemiology of Cancer. In: Woods, A., Darie, C. (eds) Advancements of Mass Spectrometry in Biomedical Research. Advances in Experimental Medicine and Biology, vol 1140. Springer, Cham. https://doi.org/10.1007/978-3-030-15950-4_44

Download citation

Publish with us

Policies and ethics

Search

Navigation